Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • WCN23-0574 THE ELLEN MEDICAL DEVICES AFFORDABLE POINT-OF-CARE PERITONEAL DIALYSIS SYSTEM - A PILOT STUDY

    Kidney International Reports Date published:

  • TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL

    Journal of the American College of Cardiology Date published:

  • Targeting the Alternative Complement Pathway with Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study

    Kidney International Reports Date published:

  • National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas

    PLOS Global Public Health Date published:

  • Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis of the CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    Nephrology Dialysis Transplantation Date published:

  • A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY

    Date published:

  • HEART FAILURE IN ASCEND-ND AND ASCEND-D

    Date published:

  • LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

    Date published:

  • Sparsentan in Patients with IgA Nephropathy (PROTECT): A Randomised Double-Blind Active-Controlled Clinical Trial

    Unknown Date published:

  • Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease

    New England Journal of Medicine Date published:

  • Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents - post hoc analyses of the ASCEND-ND and ASCEND-D trials

    Nephrology Dialysis Transplantation Date published:

  • Abstract 12404: Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin

    Circulation Date published:

  • Design and Population of the VALOR-CKD Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating the Efficacy and Safety of Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis

    Nephrology Dialysis Transplantation Date published:

  • Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis

    Journal of the American Society of Nephrology Date published:

  • Effect of Iptacopan on Proteinuria and Complement Biomarkers Over Time in IgA Nephropathy

    Journal of the American Society of Nephrology Date published: